MCM
ABBV icon

Monument Capital Management’s AbbVie ABBV Stock Holding History

Monument Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.64M Buy
6,503
+320
+5% +$68.8K 0.33% 88
2026
Q1 		$1.34M Sell
6,183
-28
-0.5% -$6.21K 0.34% 86
2025
Q4 		$1.42M Hold
6,211
– – 0.35% 85
2025
Q3 		$1.44M Sell
6,211
-310
-5% -$63.1K 0.36% 87
2025
Q2 		$1.21M Sell
6,521
-34
-0.5% -$6.32K 0.32% 87
2025
Q1 		$1.37M Sell
6,555
-2
-0% -$389 0.42% 74
2024
Q4 		$1.17M Buy
6,557
+1
+0% +$184 0.32% 73
2024
Q3 		$1.29M Sell
6,556
-1
-0% -$187 0.36% 71
2024
Q2 		$1.12M Buy
6,557
+85
+1% +$14.1K 0.33% 70
2024
Q1 		$1.18M Sell
6,472
-80
-1% -$13.8K 0.34% 74
2023
Q4 		$1.02M Sell
6,552
-857
-12% -$125K 0.33% 77
2023
Q3 		$1.1M Sell
7,409
-5,006
-40% -$735K 0.37% 73
2023
Q2 		$1.67M Sell
12,415
-5,220
-30% -$765K 0.53% 59
2023
Q1 		$2.81M Buy
17,635
+870
+5% +$133K 0.94% 30
2022
Q4 		$2.71M Buy
16,765
+3,634
+28% +$557K 0.93% 31
2022
Q3 		$1.76M Buy
13,131
+271
+2% +$38.9K 0.66% 44
2022
Q2 		$1.97M Buy
12,860
+1,933
+18% +$295K 0.74% 34
2022
Q1 		$1.77M Buy
10,927
+73
+0.7% +$10.6K 0.57% 53
2021
Q4 		$1.47M Buy
10,854
+633
+6% +$74.8K 0.46% 67
2021
Q3 		$1.1M Buy
10,221
+397
+4% +$45.4K 0.38% 72
2021
Q2 		$1.11M Buy
9,824
+2,583
+36% +$291K 0.38% 72
2021
Q1 		$784K Sell
7,241
-156
-2% -$16.7K 0.31% 73
2020
Q4 		$793K Buy
+7,397
New +$711K 0.37% 72

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Monument Capital Management's ABBV Position: Q2 2026 in Review

Monument Capital Management increased its AbbVie (ABBV) stake by 5.2% in Q2 2026, buying an estimated $68.8K and bringing the position to 6,503 shares worth $1.64M. The position accounts for 0.33% of the portfolio, ranked #88.

Monument Capital Management first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.81M in Q1 2023. 2,119 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Monument Capital Management held 6,503 shares of AbbVie worth $1.64M as of Q2 2026.
  • Monument Capital Management bought 320 AbbVie shares in Q2 2026, an estimated $68.8K.
  • AbbVie made up 0.33% of Monument Capital Management's portfolio in Q2 2026, its #88 holding.
  • Monument Capital Management first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • Monument Capital Management's AbbVie position peaked at $2.81M in Q1 2023.
  • 2,119 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Monument Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.